Compounds > levormeloxifene
Page last updated: 2024-08-23

levormeloxifene and Osteoporosis, Postmenopausal

levormeloxifene has been researched along with Osteoporosis, Postmenopausal in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's5 (83.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldstein, SR; Nanavati, N1
Christiansen, C; Nielsen, TF; Ravn, P1
Christiansen, C1
Alexandersen, P; Christiansen, C; Delmas, PD; Riis, BJ; Stakkestad, JA1
Brommage, R; Hotchkiss, CE; Kaplan, J; Lees, CJ; Nowak, J; Stavisky, R1
Bjarnason, K; Gerrits, M; Kiehr, B; Pedersen, PC; Skrumsager, BK; Watson, N1

Reviews

1 review(s) available for levormeloxifene and Osteoporosis, Postmenopausal

ArticleYear
What can be learned from the levormeloxifene experience?
    Acta obstetricia et gynecologica Scandinavica, 2006, Volume: 85, Issue:2

    Topics: Animals; Bone Density; Clinical Trials as Topic; Female; Humans; Osteoporosis, Postmenopausal; Pyrrolidines; Selective Estrogen Receptor Modulators

2006

Trials

3 trial(s) available for levormeloxifene and Osteoporosis, Postmenopausal

ArticleYear
Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study.
    American journal of obstetrics and gynecology, 2002, Volume: 187, Issue:3

    Topics: Abdominal Pain; Aged; Constipation; Endometrium; Female; Humans; Osteoporosis, Postmenopausal; Prospective Studies; Pyrrolidines; Selective Estrogen Receptor Modulators; Urinary Incontinence; Vagina

2002
Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:2

    Topics: Bone Density; Calcium; Cholesterol; Double-Blind Method; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Placebos; Pyrrolidines; Receptors, Estrogen; Triglycerides; Ultrasonography

2001
Levormeloxifene: safety, pharmacodynamics and pharmacokinetics in healthy postmenopausal women following single and multiple doses of a new selective oestrogen receptor modulator.
    British journal of clinical pharmacology, 2002, Volume: 53, Issue:3

    Topics: Administration, Oral; Aged; Area Under Curve; Double-Blind Method; Drug Administration Schedule; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Pyrrolidines; Receptors, Estrogen; Treatment Outcome

2002

Other Studies

2 other study(ies) available for levormeloxifene and Osteoporosis, Postmenopausal

ArticleYear
Sex steroid analogs.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 1999, Volume: 9 Suppl 2

    Topics: Animals; Bone Resorption; Breast Neoplasms; Estrogen Antagonists; Female; Gonadal Steroid Hormones; Hormones; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Risk; Tamoxifen

1999
Levormeloxifene prevents increased bone turnover and vertebral bone loss following ovariectomy in cynomolgus monkeys.
    Bone, 2001, Volume: 29, Issue:1

    Topics: Animals; Bone Density; Bone Remodeling; Estradiol; Humans; Lumbar Vertebrae; Macaca fascicularis; Osteoporosis; Osteoporosis, Postmenopausal; Ovariectomy; Pyrrolidines; Selective Estrogen Receptor Modulators

2001